Chambal Fertilisers and Chemicals (CHAMBLFERT) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
31 Jul, 2026Executive summary
Q1 FY27 was marked by challenging conditions from geopolitical disruptions, elevated raw material prices, and delayed monsoon, impacting fertilizer demand and supply chains.
Operating income for Q1 FY27 was INR 5,027.02 crore, down 12% year-over-year, while operating EBITDA rose 12% to INR 8,509 Mn and net profit increased 10% to INR 7,035 Mn on a standalone basis.
Profitability improved due to better product mix, operational efficiency, and timely procurement, with margin gains across CPC, SN, and biologicals.
The company advanced its TAN project, expanded its crop protection and specialty product portfolio, and continued preparatory activities for a potential fourth urea plant.
Maintains a strong pan-India presence with a 10% urea market share and robust distribution.
Financial highlights
Standalone revenue from operations was INR 5,027.02 crore, down 12% year-over-year; EBITDA rose 12% to INR 851 crore, with margins expanding to 17% from 13% last year.
Profit after tax increased 10% to INR 703 crore; PAT margin improved to 13.99% from 11.20%.
Standalone EPS for Q1 FY27 was INR 17.56; consolidated EPS was INR 13.07.
Net borrowing stood at INR 200 crore as of June 30; net debt to equity remains low at 0.01.
Subsidy received was INR 2,480 crore, nearly flat year-over-year.
Outlook and guidance
Improved monsoon and sowing activity expected to drive stronger demand in Q2.
Long-term outlook constructive, supported by National Investment Policy for Urea 2026 and ongoing capacity expansion.
Margins in complex fertilizers expected to decline as inventory costs average up, but will remain healthy.
TAN business expected to ramp up utilization and maintain better-than-budgeted margins.
Focus on launching new products in CPC, SN, seeds, and biologicals to drive future growth.
Latest events from Chambal Fertilisers and Chemicals
- EBITDA and PAT rose in FY25, led by CPC & SN growth; Rs. 5.00/share dividend recommended.CHAMBLFERT
Q4 24/259 Jul 2026 - Q3 saw strong profit and revenue growth, new product launches, and major capacity expansions.CHAMBLFERT
Q3 24/258 Jul 2026 - FY26 saw 25% revenue growth, 18% profit rise, and major TAN plant commissioning.CHAMBLFERT
Q4 25/268 Jul 2026 - EBITDA and PAT rose sharply, with zero long-term debt and strong crop protection growth.CHAMBLFERT
Q1 24/258 Jul 2026 - EBITDA and PAT surged year-over-year, supported by urea and CPCSM growth, and interim dividend declared.CHAMBLFERT
Q2 24/258 Jul 2026 - Strong revenue and profit growth, new launches, and interim dividend highlight robust performance.CHAMBLFERT
Q2 25/261 Jul 2026 - Strong Q3/9M growth driven by complex fertilizers, specialty nutrients, and TAN project progress.CHAMBLFERT
Q3 25/2612 Apr 2026 - Diversified agri-input leader with strong financials, expanding into industrial chemicals and sustainability.CHAMBLFERT
Investor presentation20 Mar 2026 - Profits and revenue rose on CPC, SN, and biologicals growth; TAN project 80% complete.CHAMBLFERT
Q1 25/2614 Oct 2025